Global Bio-MEMS Market Overview

Global Bio-MEMS Market was valued at USD 3.80 Billion in 2021 and is expected to reach USD 6.73 Billion by the year 2028, at a CAGR of 8.5%.

MEMS with biological or biomedical functions are called BioMEMS or biomedical microelectromechanical systems. MEMS are medical devices that contain biomolecules as an important component. MEMS are used in the medical industry to monitor pressure, temperature, and motion, transmit optical and electronic data transmission fluids and manipulate micro components. Bio-MEMS is a subtype of MEMS device used in biomedical research and medical applications. Bio-MEMS integrates microscope sensors, actuators, micro-optics, microfluidics, and structural components with computers and control systems. Healthcare microcontrollers are used for a variety of purposes. Bio-MEMS improve the performance of medical devices by giving them a competitive advantage. Accelerometers have improved the treatment of heart disease and used MEMS and nanotechnology to improve drug delivery.

 The Bio-MEMS device can be implanted in specific areas of the body to provide personalized medication. When the drug is delivered into the body, the delivery system takes over and adjusts the dose to increase the effectiveness of the drug and minimize the risk of side effects. The sensors in the Bio-MEMS device use specific marker molecules to track the release profile and efficacy of the drug. These indicators help doctors determine if the disease they are treating is progressing. Accelerometers, gyroscopes, pressures, microphones, ultrasound, flow meters, optical MEMS/MOEMS, thermopiles, gas sensors, and microfluidics are some of the most General applications of Bio-MEMS. Therefore, Bio-MEMS Market presents high growth prospects during the forecasted period.

Market Dynamics And Factors For Bio-MEMS Market

Drivers:

Due to the respiratory symptoms associated with the coronavirus, there is a strong demand for mechanical ventilation. Such demand will need a pressure sensor and a flow meter. These are essential for controlling gas exchange and controlling the pressure of air blown into the patient's lungs. Companies such as Medtronic and Philips Healthcare have announced that they will double or quadruple production. Pressure sensor delivery for this application will more than double in 2020, with a 7.3% increase in total delivery compared to 2019, despite the negative impact on other medical devices. The same applies to the Bio-MEMS flow meter sensor. The need to increase production from the Swiss company Sensirion will increase production capacity by 800 times. Therefore, this need is associated with sudden, urgent, but short-term demands. Stakeholders are expecting a return to normal market conditions by 2021. The need to develop diagnostic tests has also enabled Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA), as well as similar approvals from other regulatory agencies' microfluidic platforms. These tests are primarily used as point-of-care devices which can identify the presence of the virus. Such use of Bio-MEMS to detect and curb the virus has been a key driver to the growth of the Bio-MEMS market in the last 2 years.

Mobile care applications have increased in recent years due to the development and adoption of advanced technologies in the healthcare industry around the world. Companies are continually developing products for mobile health monitoring. For example, billing Inc. has developed a mobile, painless blood pressure monitor for people with chronic illnesses. In addition, the global aging of the population is another factor in the increasing acceptance of mobile health devices. With age, the proportion of people suffering from chronic illness also increases. This will ultimately lead to higher medical costs. Wearable biochemical sensors are also very popular because of their potential for personalized medicine and continuous monitoring of human health. Therefore, vendors in the market under study may be investing in the development of such Bio-MEMS sensors to enable real-time, non-invasive measurements of chemical constituents of the human body such as sweat, saliva, and tears.

Restraints:

Due to growing technology and the requirement of high-end equipment and laboratory spaces, the adoption rate is slow in many parts of the world. Developing countries lack the expertise and superior infrastructure to supplement the growth of the Bio-MEMS market. Government regulations and the non-acceptance of new technologies in diagnostics present restraining factors for Bio-MEMS Market.

Opportunities:

Coupled with recent advances in understanding genomics, proteomics, and biotechnology, the development of microtechnology opens up new and exciting opportunities for further development of applications for Bio-MEMS devices. These devices enable future biomedical and biological systems using new types of biosensing, molecular identification and monitoring, drug delivery, lab-on-a-chip technology, and microtechnology. Bio-MEMS devices provide tremendous opportunities in DNA sequencing and identification as well as Gene mutation identification. DNA sequencing is the method of shaping the nucleic acid sequence which includes a variety of methods and techniques which can determine the bases of the main nucleobase.

New technological advancement in Bio-MEMS devices enables the creation and integration into Microfluidic systems and cell sorting devices. Microfluidic system technology provides separation methods that can potentially manipulate individual cells, reduce reagent costs, enable high volume experiments, and separate and isolate areas of micro structuring of samples such as blood and other species which allows for faster reaction work compared to traditional methods of modelling.

Challenges:

One of the main challenges to the Bio-MEMS market is its high R&D costs and long product development cycles that make it unacceptable. Strict regulatory guidelines also pose challenges to the global demand for the Bio-MEMS market. Currently, Bio-MEMS technology is evolving at a substantial pace and exploring the applications in various verticals therefore initial research and adoption requires large funding which is possible in very few sectors.  In addition, the very high initial cost of setting up a clean room and foundry system is also hampering the growth of the Bio-MEMS market.

Market Segmentation

Segmentation Analysis of Bio-MEMS Market:

By Type, Bio-Medical MEMS is the dominating type segment of the Bio-MEMS market. Most MEMS used in biomedical applications act as sensors. Important sensors used during surgery (such as measuring intravascular blood pressure), long-term sensors for prostheses, advanced sensor arrays for rapid, laboratory-quality diagnostics at home. There is a wide variety of MEMS-integrated biomedical sensors, including microsensors for biomechanics, strain gauges, accelerometers, and microsensors for pneumatic biosystems. Microelectromechanical systems (MEMS) are a class of miniature devices and systems created by the micromachining process. Important dimensions for MEMS components range from 100 nm to 1000 µm. MEMS technology is a pioneer in the relatively popular field of nanotechnology and bio-medical field referring to science, engineering, and technology from less than 100 nm to the atomic scale.  MEMS components with dimensions in the millimetre range are sometimes referred to as mesoscale MEMS devices. Therefore, it is used in a highly lucrative area of research and development of medical science and boosting the Bio-MEMS Market.

By Application, Diagnostics is the dominating in the Bio-MEMS Market. Bio-MEMS is revolutionizing medicine. Clinical applications of bio-MEMS include both diagnostic and therapeutic applications such as actuators for drug delivery and disease monitoring. BioMEMS used in diagnostics Bio-MEMS uses microfluidic components. The integrated fluid microchip enables direct separation, chemical reaction, and calibration-free analytical measurements on very small volumes of complex samples such as whole blood and contaminated environmental samples. This technology is suitable for applications such as remote clinical diagnosis and environmental sensing. The Lab on a Chip (LOC) system enables sample processing, mixing, dilution, electrophoresis, and chromatographic separation, staining, and detection in individual micro-integrated systems.

By End User, Pharmaceutical is dominating in the End User segment in the Bio-MEMS Market. The pharmaceutical industry is expected to show significant growth over the forecast period. In the process of technological advancement, automation has penetrated the pharmaceutical industry, increasing the opportunities for BioMEMS in this area. A microfabrication platform with integrated BioMEMS and nanofabrication devices treats by improving bioavailability and biodistribution and providing technologies for targeted drug delivery, timed drug release, and triggered drug release. It is used to dramatically improve the effectiveness of the drug. Different biomedical samples need to be used to detect different types of illnesses. A well-developed microfluidic processor can be used in combination with other MEMS components to separate and analyse certain types of biomolecules from the specimen. Therefore, the vast market of pharmaceuticals all over the globe and adoption of Bio-MEMES in various applications boost the Bio-MEMS Market.           

Regional Analysis of Bio-MEMS Market:

North America is the dominating in Bio-MEMS Market. The North American region is one of the earliest adopters for emerging technologies as technology companies in the region may invest in and indulge in the commercialization of products on the market. With the recent increase in the incidence of chronic illnesses in the United States, public health concerns continue. Currently, at least one in six Americans suffers from one of the chronic illnesses, according to the Centers for Disease Control and Prevention. Companies in the region are investing heavily in self-monitoring devices such as point-of-contact test applications and blood glucose tests. It reduces medical costs and saves time. Such investments and commercialization of these products are expected to generate demand for the BioMEMS market in the region. In addition, companies in the region are looking for growth opportunities for BioMEMS applications by expanding manufacturing facilities that may drive demand in the North American market. For example, Siemens Helathneers recently announced the expansion of its Canadian production facility. The company plans to offer a wireless solution that can perform comprehensive patient blood analysis tests in less than a minute. Such advances in the field and government support create a potent environment for the growth of the Bio-MEMS Market.

The Asia Pacific is one of the fastest-growing regions in the Bio-MEMS Market due to huge investment in the countries like India, China, Japan, and South Korea. China has numerous ongoing projects of genetic modification and the use of the micro-electromechanical system for diagnostics and improving treatment prospects. Huge investments in Indian Bio-Tach companies from western investors create a healthy environment for the growth of the Bio-MEMS Market.

Players Covered in Bio-MEMS Market are:

• Integrated Sensing System Inc. (ISSYS)
• Bluechiip Ltd
• Given Imaging
• Cepheid Inc
• TDK Corporation
• SPTS Technologies Ltd
• Boston Scientific Heimann Sensor
• Lepu Medical Technology
• Nanopass Technologies
• United Gene High-Tech Group Micron Technology
• Abbott Diagnostics
• Caliper Life Sciences
• Analog Devices
• Tronics
• Nova Biomedical
• ForteBio
• Biosensors International Ltd and others major players.

Covid-19 Impact on Bio-MEMS Market

Wearables connected medical devices, and remote monitoring devices are gaining increasing attention in the healthcare sector as the COVID 19 pandemic continues to impact the economy. Throughout the year of the pandemic, BioMEMS technology saw demand for ventilators and equipment that faced major shortages in some regions.  Also, Bio-MEMS devices are being used in the detection of viruses which can help to curb the virus spread. This application creates prospects and high funding to develop high-performing Bio-Medical devices for the diagnosis and treatment of covid19 which helped to boost the BioMEMS Market. Continued use of connected technology and remote patient care after the pandemic will accelerate the trend in the BioMEMS market.

Key Industry Developments In Bio-MEMS Market

• June 2020, Technological development in Organ on a chip is a relatively new technology that mimics and simulates multi-level organ systems on the bench using a combination of microfluidics, biomedical microelectromechanical systems (or bioMEMS), and biomaterials. This enables real-world in vitro studies such as drug testing and disease research while developing useful implantable functional assistants. Brain, liver, heart, kidney, lung, and intestinal functions are all successfully implemented on the chip platform and integrate different types of electronic devices.
• In September 2019, Teledyne Digital Imaging Inc has acquired Micralyne Inc, a private foundry that supplies microelectromechanical systems or MEMS devices. In particular, Micralyne has exclusive microfluidic technology for biotechnology applications and the capabilities of non-silicon-based MEMS such as gold, polymers, etc. that the human body often required compatibility.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application
 3.3 By Distribution Channel

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Bio-MEMS Market by Type
 5.1 Bio-MEMS Market Overview Snapshot and Growth Engine
 5.2 Bio-MEMS Market Overview
 5.3 Bio-Medical MEMS
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Bio-Medical MEMS: Grographic Segmentation
 5.4 Biotechnology MEMS
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Biotechnology MEMS: Grographic Segmentation

Chapter 6: Bio-MEMS Market by Application
 6.1 Bio-MEMS Market Overview Snapshot and Growth Engine
 6.2 Bio-MEMS Market Overview
 6.3 Sample Preparation
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Sample Preparation: Grographic Segmentation
 6.4 Screening
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Screening: Grographic Segmentation
 6.5 Diagnostics
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Diagnostics: Grographic Segmentation
 6.6 Monitoring
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2016-2028F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Monitoring: Grographic Segmentation
 6.7 Others
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size (2016-2028F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Others: Grographic Segmentation

Chapter 7: Bio-MEMS Market by Distribution Channel
 7.1 Bio-MEMS Market Overview Snapshot and Growth Engine
 7.2 Bio-MEMS Market Overview
 7.3 Home Diagnostics
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Home Diagnostics: Grographic Segmentation
 7.4 Hospitals
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Hospitals: Grographic Segmentation
 7.5 Pharmaceutical
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Pharmaceutical: Grographic Segmentation
 7.6 Agricultural Industry
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Agricultural Industry: Grographic Segmentation
 7.7 Others
  7.7.1 Introduction and Market Overview
  7.7.2 Historic and Forecasted Market Size (2016-2028F)
  7.7.3 Key Market Trends, Growth Factors and Opportunities
  7.7.4 Others: Grographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Bio-MEMS Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Ansoff Matrix
  8.1.5 Bio-MEMS Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Bio-MEMS Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 INTEGRATED SENSING SYSTEM INC. (ISSYS)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 BLUECHIIP LTD
 8.4 GIVEN IMAGING
 8.5 CEPHEID INC
 8.6 TDK CORPORATION
 8.7 SPTS TECHNOLOGIES LTD
 8.8 BOSTON SCIENTIFIC HEIMANN SENSOR
 8.9 LEPU MEDICAL TECHNOLOGY
 8.10 NANOPASS TECHNOLOGIES
 8.11 UNITED GENE HIGH-TECH GROUP MICRON TECHNOLOGY
 8.12 ABBOTT DIAGNOSTICS
 8.13 CALIPER LIFE SCIENCES
 8.14 ANALOG DEVICES
 8.15 TRONICS
 8.16 NOVA BIOMEDICAL
 8.17 FORTEBIO
 8.18 BIOSENSORS INTERNATIONAL LTD
 8.19 OTHER MAJOR PLAYERS

Chapter 9: Global Bio-MEMS Market Analysis, Insights and Forecast, 2016-2028
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Type
  9.2.1 Bio-Medical MEMS
  9.2.2 Biotechnology MEMS
 9.3 Historic and Forecasted Market Size By Application
  9.3.1 Sample Preparation
  9.3.2 Screening
  9.3.3 Diagnostics
  9.3.4 Monitoring
  9.3.5 Others
 9.4 Historic and Forecasted Market Size By Distribution Channel
  9.4.1 Home Diagnostics
  9.4.2 Hospitals
  9.4.3 Pharmaceutical
  9.4.4 Agricultural Industry
  9.4.5 Others

Chapter 10: North America Bio-MEMS Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Bio-Medical MEMS
  10.4.2 Biotechnology MEMS
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Sample Preparation
  10.5.2 Screening
  10.5.3 Diagnostics
  10.5.4 Monitoring
  10.5.5 Others
 10.6 Historic and Forecasted Market Size By Distribution Channel
  10.6.1 Home Diagnostics
  10.6.2 Hospitals
  10.6.3 Pharmaceutical
  10.6.4 Agricultural Industry
  10.6.5 Others
 10.7 Historic and Forecast Market Size by Country
  10.7.1 U.S.
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Europe Bio-MEMS Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Bio-Medical MEMS
  11.4.2 Biotechnology MEMS
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Sample Preparation
  11.5.2 Screening
  11.5.3 Diagnostics
  11.5.4 Monitoring
  11.5.5 Others
 11.6 Historic and Forecasted Market Size By Distribution Channel
  11.6.1 Home Diagnostics
  11.6.2 Hospitals
  11.6.3 Pharmaceutical
  11.6.4 Agricultural Industry
  11.6.5 Others
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Germany
  11.7.2 U.K.
  11.7.3 France
  11.7.4 Italy
  11.7.5 Russia
  11.7.6 Spain
  11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Bio-MEMS Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Bio-Medical MEMS
  12.4.2 Biotechnology MEMS
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Sample Preparation
  12.5.2 Screening
  12.5.3 Diagnostics
  12.5.4 Monitoring
  12.5.5 Others
 12.6 Historic and Forecasted Market Size By Distribution Channel
  12.6.1 Home Diagnostics
  12.6.2 Hospitals
  12.6.3 Pharmaceutical
  12.6.4 Agricultural Industry
  12.6.5 Others
 12.7 Historic and Forecast Market Size by Country
  12.7.1 China
  12.7.2 India
  12.7.3 Japan
  12.7.4 Singapore
  12.7.5 Australia
  12.7.6 New Zealand
  12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Bio-MEMS Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Bio-Medical MEMS
  13.4.2 Biotechnology MEMS
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Sample Preparation
  13.5.2 Screening
  13.5.3 Diagnostics
  13.5.4 Monitoring
  13.5.5 Others
 13.6 Historic and Forecasted Market Size By Distribution Channel
  13.6.1 Home Diagnostics
  13.6.2 Hospitals
  13.6.3 Pharmaceutical
  13.6.4 Agricultural Industry
  13.6.5 Others
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Turkey
  13.7.2 Saudi Arabia
  13.7.3 Iran
  13.7.4 UAE
  13.7.5 Africa
  13.7.6 Rest of MEA

Chapter 14: South America Bio-MEMS Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Bio-Medical MEMS
  14.4.2 Biotechnology MEMS
 14.5 Historic and Forecasted Market Size By Application
  14.5.1 Sample Preparation
  14.5.2 Screening
  14.5.3 Diagnostics
  14.5.4 Monitoring
  14.5.5 Others
 14.6 Historic and Forecasted Market Size By Distribution Channel
  14.6.1 Home Diagnostics
  14.6.2 Hospitals
  14.6.3 Pharmaceutical
  14.6.4 Agricultural Industry
  14.6.5 Others
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Brazil
  14.7.2 Argentina
  14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. BIO-MEMS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. BIO-MEMS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. BIO-MEMS MARKET COMPETITIVE RIVALRY
TABLE 005. BIO-MEMS MARKET THREAT OF NEW ENTRANTS
TABLE 006. BIO-MEMS MARKET THREAT OF SUBSTITUTES
TABLE 007. BIO-MEMS MARKET BY TYPE
TABLE 008. BIO-MEDICAL MEMS MARKET OVERVIEW (2016-2028)
TABLE 009. BIOTECHNOLOGY MEMS MARKET OVERVIEW (2016-2028)
TABLE 010. BIO-MEMS MARKET BY APPLICATION
TABLE 011. SAMPLE PREPARATION MARKET OVERVIEW (2016-2028)
TABLE 012. SCREENING MARKET OVERVIEW (2016-2028)
TABLE 013. DIAGNOSTICS MARKET OVERVIEW (2016-2028)
TABLE 014. MONITORING MARKET OVERVIEW (2016-2028)
TABLE 015. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 016. BIO-MEMS MARKET BY DISTRIBUTION CHANNEL
TABLE 017. HOME DIAGNOSTICS MARKET OVERVIEW (2016-2028)
TABLE 018. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 019. PHARMACEUTICAL MARKET OVERVIEW (2016-2028)
TABLE 020. AGRICULTURAL INDUSTRY MARKET OVERVIEW (2016-2028)
TABLE 021. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 022. NORTH AMERICA BIO-MEMS MARKET, BY TYPE (2016-2028)
TABLE 023. NORTH AMERICA BIO-MEMS MARKET, BY APPLICATION (2016-2028)
TABLE 024. NORTH AMERICA BIO-MEMS MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 025. N BIO-MEMS MARKET, BY COUNTRY (2016-2028)
TABLE 026. EUROPE BIO-MEMS MARKET, BY TYPE (2016-2028)
TABLE 027. EUROPE BIO-MEMS MARKET, BY APPLICATION (2016-2028)
TABLE 028. EUROPE BIO-MEMS MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 029. BIO-MEMS MARKET, BY COUNTRY (2016-2028)
TABLE 030. ASIA PACIFIC BIO-MEMS MARKET, BY TYPE (2016-2028)
TABLE 031. ASIA PACIFIC BIO-MEMS MARKET, BY APPLICATION (2016-2028)
TABLE 032. ASIA PACIFIC BIO-MEMS MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 033. BIO-MEMS MARKET, BY COUNTRY (2016-2028)
TABLE 034. MIDDLE EAST & AFRICA BIO-MEMS MARKET, BY TYPE (2016-2028)
TABLE 035. MIDDLE EAST & AFRICA BIO-MEMS MARKET, BY APPLICATION (2016-2028)
TABLE 036. MIDDLE EAST & AFRICA BIO-MEMS MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 037. BIO-MEMS MARKET, BY COUNTRY (2016-2028)
TABLE 038. SOUTH AMERICA BIO-MEMS MARKET, BY TYPE (2016-2028)
TABLE 039. SOUTH AMERICA BIO-MEMS MARKET, BY APPLICATION (2016-2028)
TABLE 040. SOUTH AMERICA BIO-MEMS MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 041. BIO-MEMS MARKET, BY COUNTRY (2016-2028)
TABLE 042. INTEGRATED SENSING SYSTEM INC. (ISSYS): SNAPSHOT
TABLE 043. INTEGRATED SENSING SYSTEM INC. (ISSYS): BUSINESS PERFORMANCE
TABLE 044. INTEGRATED SENSING SYSTEM INC. (ISSYS): PRODUCT PORTFOLIO
TABLE 045. INTEGRATED SENSING SYSTEM INC. (ISSYS): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. BLUECHIIP LTD: SNAPSHOT
TABLE 046. BLUECHIIP LTD: BUSINESS PERFORMANCE
TABLE 047. BLUECHIIP LTD: PRODUCT PORTFOLIO
TABLE 048. BLUECHIIP LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. GIVEN IMAGING: SNAPSHOT
TABLE 049. GIVEN IMAGING: BUSINESS PERFORMANCE
TABLE 050. GIVEN IMAGING: PRODUCT PORTFOLIO
TABLE 051. GIVEN IMAGING: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. CEPHEID INC: SNAPSHOT
TABLE 052. CEPHEID INC: BUSINESS PERFORMANCE
TABLE 053. CEPHEID INC: PRODUCT PORTFOLIO
TABLE 054. CEPHEID INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. TDK CORPORATION: SNAPSHOT
TABLE 055. TDK CORPORATION: BUSINESS PERFORMANCE
TABLE 056. TDK CORPORATION: PRODUCT PORTFOLIO
TABLE 057. TDK CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. SPTS TECHNOLOGIES LTD: SNAPSHOT
TABLE 058. SPTS TECHNOLOGIES LTD: BUSINESS PERFORMANCE
TABLE 059. SPTS TECHNOLOGIES LTD: PRODUCT PORTFOLIO
TABLE 060. SPTS TECHNOLOGIES LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. BOSTON SCIENTIFIC HEIMANN SENSOR: SNAPSHOT
TABLE 061. BOSTON SCIENTIFIC HEIMANN SENSOR: BUSINESS PERFORMANCE
TABLE 062. BOSTON SCIENTIFIC HEIMANN SENSOR: PRODUCT PORTFOLIO
TABLE 063. BOSTON SCIENTIFIC HEIMANN SENSOR: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. LEPU MEDICAL TECHNOLOGY: SNAPSHOT
TABLE 064. LEPU MEDICAL TECHNOLOGY: BUSINESS PERFORMANCE
TABLE 065. LEPU MEDICAL TECHNOLOGY: PRODUCT PORTFOLIO
TABLE 066. LEPU MEDICAL TECHNOLOGY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. NANOPASS TECHNOLOGIES: SNAPSHOT
TABLE 067. NANOPASS TECHNOLOGIES: BUSINESS PERFORMANCE
TABLE 068. NANOPASS TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 069. NANOPASS TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. UNITED GENE HIGH-TECH GROUP MICRON TECHNOLOGY: SNAPSHOT
TABLE 070. UNITED GENE HIGH-TECH GROUP MICRON TECHNOLOGY: BUSINESS PERFORMANCE
TABLE 071. UNITED GENE HIGH-TECH GROUP MICRON TECHNOLOGY: PRODUCT PORTFOLIO
TABLE 072. UNITED GENE HIGH-TECH GROUP MICRON TECHNOLOGY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. ABBOTT DIAGNOSTICS: SNAPSHOT
TABLE 073. ABBOTT DIAGNOSTICS: BUSINESS PERFORMANCE
TABLE 074. ABBOTT DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 075. ABBOTT DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. CALIPER LIFE SCIENCES: SNAPSHOT
TABLE 076. CALIPER LIFE SCIENCES: BUSINESS PERFORMANCE
TABLE 077. CALIPER LIFE SCIENCES: PRODUCT PORTFOLIO
TABLE 078. CALIPER LIFE SCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 078. ANALOG DEVICES: SNAPSHOT
TABLE 079. ANALOG DEVICES: BUSINESS PERFORMANCE
TABLE 080. ANALOG DEVICES: PRODUCT PORTFOLIO
TABLE 081. ANALOG DEVICES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 081. TRONICS: SNAPSHOT
TABLE 082. TRONICS: BUSINESS PERFORMANCE
TABLE 083. TRONICS: PRODUCT PORTFOLIO
TABLE 084. TRONICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 084. NOVA BIOMEDICAL: SNAPSHOT
TABLE 085. NOVA BIOMEDICAL: BUSINESS PERFORMANCE
TABLE 086. NOVA BIOMEDICAL: PRODUCT PORTFOLIO
TABLE 087. NOVA BIOMEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 087. FORTEBIO: SNAPSHOT
TABLE 088. FORTEBIO: BUSINESS PERFORMANCE
TABLE 089. FORTEBIO: PRODUCT PORTFOLIO
TABLE 090. FORTEBIO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 090. BIOSENSORS INTERNATIONAL LTD: SNAPSHOT
TABLE 091. BIOSENSORS INTERNATIONAL LTD: BUSINESS PERFORMANCE
TABLE 092. BIOSENSORS INTERNATIONAL LTD: PRODUCT PORTFOLIO
TABLE 093. BIOSENSORS INTERNATIONAL LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 093. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 094. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 095. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 096. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. BIO-MEMS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. BIO-MEMS MARKET OVERVIEW BY TYPE
FIGURE 012. BIO-MEDICAL MEMS MARKET OVERVIEW (2016-2028)
FIGURE 013. BIOTECHNOLOGY MEMS MARKET OVERVIEW (2016-2028)
FIGURE 014. BIO-MEMS MARKET OVERVIEW BY APPLICATION
FIGURE 015. SAMPLE PREPARATION MARKET OVERVIEW (2016-2028)
FIGURE 016. SCREENING MARKET OVERVIEW (2016-2028)
FIGURE 017. DIAGNOSTICS MARKET OVERVIEW (2016-2028)
FIGURE 018. MONITORING MARKET OVERVIEW (2016-2028)
FIGURE 019. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 020. BIO-MEMS MARKET OVERVIEW BY DISTRIBUTION CHANNEL
FIGURE 021. HOME DIAGNOSTICS MARKET OVERVIEW (2016-2028)
FIGURE 022. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 023. PHARMACEUTICAL MARKET OVERVIEW (2016-2028)
FIGURE 024. AGRICULTURAL INDUSTRY MARKET OVERVIEW (2016-2028)
FIGURE 025. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 026. NORTH AMERICA BIO-MEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. EUROPE BIO-MEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. ASIA PACIFIC BIO-MEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. MIDDLE EAST & AFRICA BIO-MEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. SOUTH AMERICA BIO-MEMS MARKET OVERVIEW BY COUNTRY (2016-2028)